These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 824135)
1. Leukocyte-dependent antibody in sheep immunized with murine mastocytoma cells. Grant CK; Adams E; Miller HR Eur J Immunol; 1975 May; 5(5):324-30. PubMed ID: 824135 [TBL] [Abstract][Full Text] [Related]
2. Appearance of cytolytic antibodies in sheep lymph following immunisation with tumour cells. Identification of antibody subclasses. Grant CK; Adams EP; Nass M Aust J Exp Biol Med Sci; 1976 Oct; 53(5):381-7. PubMed ID: 820322 [TBL] [Abstract][Full Text] [Related]
4. Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC). Sato N; Yabuki Y; Toh K; Ishii Y; Kikuchi K Immunology; 1979 Mar; 36(3):421-6. PubMed ID: 437836 [TBL] [Abstract][Full Text] [Related]
5. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. Ralph P; Prichard J; Cohn M J Immunol; 1975 Feb; 114(2 pt 2):898-905. PubMed ID: 1089721 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effector mechanisms detected in the central lymph of sheep followin immunisation with allogeneic or xenogeneic cell suspensions. Direct lymphocyte mediated target cell killing and immunoblast synthesis of complement- and leukocyte-dependent antibodies. Grant CK; Cameron B Cell Immunol; 1975 Jul; 18(1):58-69. PubMed ID: 806356 [No Abstract] [Full Text] [Related]
7. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect. Igarashi T; Okada M; Kishimoto S; Yamamura Y Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916 [TBL] [Abstract][Full Text] [Related]
8. The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P-815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response. Kölsch E Eur J Immunol; 1975 Aug; 5(8):527-32. PubMed ID: 824139 [TBL] [Abstract][Full Text] [Related]
9. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells. Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777 [TBL] [Abstract][Full Text] [Related]
10. Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants. Stevenson FK; Elliott EV Immunology; 1978 Feb; 34(2):353-8. PubMed ID: 75184 [TBL] [Abstract][Full Text] [Related]
11. Suppressor cells in the spleen of tumor-allosensitized mice. Argyris BF Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979 [TBL] [Abstract][Full Text] [Related]
12. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies. Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634 [TBL] [Abstract][Full Text] [Related]
13. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography. Gupta RK; Silver HK; Reisfeld RA; Morton DL Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. II. The mouse nonadherent K cell. Greenberg AH; Shen L; Walker L; Arnaiz-Villena A; Roitt IM Eur J Immunol; 1976 Jul; 5(7):474-80. PubMed ID: 976311 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay. Greenberg AH; Shen L; Medley G Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417 [TBL] [Abstract][Full Text] [Related]
17. Studies on the association of alpha2-macroglobulin with T, B and K cells. James K; Tunstall AM; McCormick JN; Calder EA; Urbaniak SJ; Henney CS Isr J Med Sci; 1975 Dec; 11(12):1342-7. PubMed ID: 56325 [No Abstract] [Full Text] [Related]
18. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement. Arnaiz-Villena A; Jones B; Roitt IM Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554 [TBL] [Abstract][Full Text] [Related]
19. Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities. Hunninghake GW; Fauci AS J Immunol; 1976 Jul; 117(1):337-42. PubMed ID: 932431 [TBL] [Abstract][Full Text] [Related]
20. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells. Tamerius JD; Hellström I J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783 [No Abstract] [Full Text] [Related] [Next] [New Search]